• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗溶血尿毒综合征注册中心的建立与初步实施。

Development and pilot implementation of Iranian Hemolytic Uremic Syndrome Registry.

机构信息

Department of Health Information Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.

Aliasghar Clinical Research Development Center (AACRDC), Aliasghar Children Hospital, Department of Pediatrics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

出版信息

Orphanet J Rare Dis. 2022 Jun 16;17(1):228. doi: 10.1186/s13023-022-02376-9.

DOI:10.1186/s13023-022-02376-9
PMID:35710568
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9205084/
Abstract

BACKGROUND

Patients with Hemolytic Uremic Syndrome (HUS) face late diagnosis and lack of appropriate treatment because of a lack of knowledge and experience in this field. A prerequisite for such knowledge is the development of research infrastructures such as a registry system. Therefore, this study aimed to develop and describe the HUS registry in accordance with the Iranian health system and implement its software system.

METHODS

We first interviewed 10 pediatric nephrologists and after analyzing the interviews, we identified the features and requirements and the data related to HUS. Then, during two rounds of the Delphi technique (the first round with 23 participants and the second round with 18 participants), the model of this registry was finalized based on the agreement of at least 75% of specialists. At the next step, based on the agreed requirements, IRI.HUS.Reg (Iranian Hemolytic Uremic Syndrome Registry) software was developed and implemented in a pediatric hospital.

RESULTS

We classified 369 meaning units of interviews in 41 codes and 7 final themes including purposes of the registry (10 codes), inclusion criteria (7 codes), data collection method (4 codes), data quality control (6 codes), data sources (4 codes), data analysis (3 codes) and software features (7 codes). These 7 feature groups (67 subgroups) and 12 data classes (138 data elements) include demographic data, referrals, examinations, clinical signs, causes, laboratory tests, medical histories, paraclinical measures, treatments, outcomes, patient's status at discharge, and follow-up data were reviewed by the Delphi panelists, and finally, 64 features and 131 data elements were accepted by at least 78% agreement. Then, we developed and implemented a registry software system in a hospital.

CONCLUSION

We implemented IRI.HUS.Reg based on related features, 12 data classes agreed by specialists, literature review, and comparison with other existing registries. Therefore, the data collected in this registry can be compared with other data from existing registries in other countries.

摘要

背景

由于缺乏该领域的知识和经验,溶血性尿毒症综合征(HUS)患者面临着诊断延迟和缺乏适当治疗的问题。开展此类研究的前提是建立研究基础设施,例如登记系统。因此,本研究旨在根据伊朗卫生系统开发和描述 HUS 登记系统,并实施其软件系统。

方法

我们首先对 10 名儿科肾病学家进行了访谈,在分析访谈内容后,我们确定了 HUS 登记系统的特征和要求以及相关数据。然后,通过两轮德尔菲技术(第一轮有 23 名参与者,第二轮有 18 名参与者),根据至少 75%专家的一致意见,确定了该登记系统的模型。下一步,根据达成的要求,在一家儿科医院开发并实施了 IRI.HUS.Reg(伊朗溶血性尿毒症综合征登记系统)软件。

结果

我们对 369 个访谈的意义单位进行了分类,形成 41 个代码和 7 个最终主题,包括登记系统的目的(10 个代码)、纳入标准(7 个代码)、数据收集方法(4 个代码)、数据质量控制(6 个代码)、数据来源(4 个代码)、数据分析(3 个代码)和软件功能(7 个代码)。这些 7 个特征组(67 个子组)和 12 个数据类(138 个数据元素)包括人口统计学数据、转诊、检查、临床症状、病因、实验室检查、病史、辅助检查、治疗、结局、出院时患者状况和随访数据。德尔菲专家小组对这些内容进行了审查,最终至少有 78%的专家同意了 64 个特征和 131 个数据元素。然后,我们在一家医院开发并实施了一个登记系统软件。

结论

我们根据相关特征、专家同意的 12 个数据类、文献回顾以及与其他现有登记系统的比较,实施了 IRI.HUS.Reg。因此,该登记系统中收集的数据可以与其他国家现有登记系统中的数据进行比较。

相似文献

1
Development and pilot implementation of Iranian Hemolytic Uremic Syndrome Registry.伊朗溶血尿毒综合征注册中心的建立与初步实施。
Orphanet J Rare Dis. 2022 Jun 16;17(1):228. doi: 10.1186/s13023-022-02376-9.
2
Lessons learned from hemolytic uremic syndrome registries: recommendations for implementation.从溶血尿毒综合征登记中吸取的经验教训:实施建议。
Orphanet J Rare Dis. 2021 May 25;16(1):240. doi: 10.1186/s13023-021-01871-9.
3
Hemolytic-uremic syndrome in adolescents.青少年溶血性尿毒症综合征
Arch Pediatr Adolesc Med. 1997 Feb;151(2):165-9. doi: 10.1001/archpedi.1997.02170390055010.
4
The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS.俄克拉荷马血栓性血小板减少性紫癜-溶血性尿毒症综合征(TTP-HUS)登记处:临床诊断为TTP-HUS患者的社区视角。
Semin Hematol. 2004 Jan;41(1):60-7. doi: 10.1053/j.seminhematol.2003.10.001.
5
Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.溶血性尿毒症综合征:与炎症性肠病发作的鉴别诊断。
Acta Biomed. 2018 Dec 17;89(9-S):153-157. doi: 10.23750/abm.v89i9-S.7911.
6
Typical and Atypical Hemolytic Uremic Syndrome in the Critically Ill.危重症患者中的典型和非典型溶血尿毒综合征
Crit Care Clin. 2020 Apr;36(2):333-356. doi: 10.1016/j.ccc.2019.11.004. Epub 2020 Jan 31.
7
Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome.非典型和复发性溶血尿毒综合征的流行病学、临床表现及病理生理学
Semin Thromb Hemost. 2006 Mar;32(2):113-20. doi: 10.1055/s-2006-939767.
8
TTP/HUS and prognosis: the syndrome and the disease(s).血栓性血小板减少性紫癜/溶血尿毒综合征与预后:综合征与疾病
Kidney Int Suppl. 2009 Feb(112):S59-61. doi: 10.1038/ki.2008.623.
9
Hemolytic Uremic Syndrome: A Contemporary Pediatric Experience.溶血尿毒综合征:当代儿科经验。
Nephron. 2020;144(3):109-117. doi: 10.1159/000505401. Epub 2020 Jan 14.
10
The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: evaluation, management, and long-term outcomes experience of the Oklahoma TTP-HUS Registry, 1989-2007.血栓性血小板减少性紫癜和溶血性尿毒症综合征:1989 - 2007年俄克拉荷马州血栓性血小板减少性紫癜-溶血性尿毒症综合征登记处的评估、管理及长期预后经验
Kidney Int Suppl. 2009 Feb(112):S52-4. doi: 10.1038/ki.2008.622.

本文引用的文献

1
Barriers and facilitators for disease registry systems: a mixed-method study.疾病登记系统的障碍和促进因素:一项混合方法研究。
BMC Med Inform Decis Mak. 2022 Apr 11;22(1):97. doi: 10.1186/s12911-022-01840-7.
2
Modified Delphi procedure-based expert consensus on endpoints for an international disease registry for Metachromatic Leukodystrophy: The European Metachromatic Leukodystrophy initiative (MLDi).德尔菲法改良程序基础上的国际异染性脑白质营养不良疾病登记研究终点专家共识:欧洲异染性脑白质营养不良倡议(MLDi)。
Orphanet J Rare Dis. 2022 Feb 14;17(1):48. doi: 10.1186/s13023-022-02189-w.
3
Barriers and facilitators for the implementation of health condition and outcome registry systems: a systematic literature review.
实施健康状况和结果登记系统的障碍和促进因素:系统文献回顾。
J Am Med Inform Assoc. 2022 Mar 15;29(4):723-734. doi: 10.1093/jamia/ocab293.
4
Lessons learned from hemolytic uremic syndrome registries: recommendations for implementation.从溶血尿毒综合征登记中吸取的经验教训:实施建议。
Orphanet J Rare Dis. 2021 May 25;16(1):240. doi: 10.1186/s13023-021-01871-9.
5
Baseline characteristics of patients with atypical haemolytic uraemic syndrome (aHUS): The Australian cohort in a global aHUS registry.非典型溶血性尿毒综合征(aHUS)患者的基线特征:全球 aHUS 注册研究中的澳大利亚队列。
Nephrology (Carlton). 2020 Sep;25(9):683-690. doi: 10.1111/nep.13722. Epub 2020 May 31.
6
The Prevalence and Incidence of Hemolytic Uremic Syndrome in Iran, a Systematic Review and Meta-analysis.伊朗溶血尿毒综合征的患病率和发病率:系统评价和荟萃分析。
Iran J Kidney Dis. 2020 May;14(3):173-183.
7
Epidemiology of Atypical Hemolytic Uremic Syndrome: A Systematic Literature Review.非典型溶血尿毒综合征的流行病学:一项系统文献综述
Clin Epidemiol. 2020 Mar 12;12:295-305. doi: 10.2147/CLEP.S245642. eCollection 2020.
8
Eculizumab Safety: Five-Year Experience From the Global Atypical Hemolytic Uremic Syndrome Registry.依库珠单抗安全性:来自全球非典型溶血性尿毒症综合征注册研究的五年经验
Kidney Int Rep. 2019 Aug 2;4(11):1568-1576. doi: 10.1016/j.ekir.2019.07.016. eCollection 2019 Nov.
9
Medical students' knowledge and opinions about rare diseases: A case study from Poland.医学生对罕见病的知识与看法:来自波兰的一个案例研究。
Intractable Rare Dis Res. 2019 Nov;8(4):252-259. doi: 10.5582/irdr.2019.01099.
10
Distinct genetic variation and heterogeneity of the Iranian population.伊朗人群的独特遗传变异和异质性。
PLoS Genet. 2019 Sep 24;15(9):e1008385. doi: 10.1371/journal.pgen.1008385. eCollection 2019 Sep.